BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32100920)

  • 1. Interaction between miRNAs and signaling cascades of Wnt pathway in chronic lymphocytic leukemia.
    Bhattacharya M; Sharma AR; Sharma G; Patra BC; Lee SS; Chakraborty C
    J Cell Biochem; 2020 Nov; 121(11):4654-4666. PubMed ID: 32100920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
    Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
    J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
    Yao QM; Li PP; Liang SM; Lu K; Zhu XJ; Liu YX; Zhang F; Yuan T; Wang X
    Int J Clin Exp Pathol; 2015; 8(7):7921-8. PubMed ID: 26339357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microRNAs in chronic lymphocytic leukemia (Review).
    Zhou XX; Wang X
    Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway.
    Xia L; Wu L; Bao J; Li Q; Chen X; Xia H; Xia R
    Biochem Biophys Res Commun; 2018 Sep; 503(1):385-390. PubMed ID: 29902450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study.
    Franiak-Pietryga I; Maciejewski H; Ziemba B; Appelhans D; Voit B; Robak T; Jander M; Treliński J; Bryszewska M; Borowiec M
    Macromol Biosci; 2017 Nov; 17(11):. PubMed ID: 28762636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of signaling pathways and miRNAs in chronic lymphocytic leukemia.
    Li PP; Wang X
    Chin Med J (Engl); 2013 Nov; 126(21):4175-82. PubMed ID: 24229693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
    Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
    Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways.
    Doghish AS; Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Fathi D; Elsakka EGE
    Pathol Res Pract; 2023 Mar; 243():154363. PubMed ID: 36764011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
    Bagacean C; Iuga CA; Bordron A; Tempescul A; Pralea IE; Bernard D; Cornen M; Bergot T; Le Dantec C; Brooks W; Saad H; Ianotto JC; Pers JO; Zdrenghea M; Berthou C; Renaudineau Y
    J Leukoc Biol; 2022 Feb; 111(2):313-325. PubMed ID: 34288092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
    Kou Z; Mao M; Liu H; Wang X; Wang Z; Gu Z; Lang T; Nie Y; Wang Y; Huang Q; An L; Zhang X; Fu L; Li Y
    Biomark Med; 2021 Jun; 15(9):623-635. PubMed ID: 34039026
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
    Lu D; Zhao Y; Tawatao R; Cottam HB; Sen M; Leoni LM; Kipps TJ; Corr M; Carson DA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3118-23. PubMed ID: 14973184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemia.
    Bottoni A; Calin GA
    Microrna; 2014; 2(3):158-64. PubMed ID: 25069439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
    Janovska P; Poppova L; Plevova K; Plesingerova H; Behal M; Kaucka M; Ovesna P; Hlozkova M; Borsky M; Stehlikova O; Brychtova Y; Doubek M; Machalova M; Baskar S; Kozubik A; Pospisilova S; Pavlova S; Bryja V
    Clin Cancer Res; 2016 Jan; 22(2):459-69. PubMed ID: 26240275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
    Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
    PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV.
    Poppova L; Janovska P; Plevova K; Radova L; Plesingerova H; Borsky M; Kotaskova J; Kantorova B; Hlozkova M; Figulova J; Brychtova Y; Machalova M; Urik M; Doubek M; Kozubik A; Pospisilova S; Pavlova S; Bryja V
    Br J Haematol; 2016 Dec; 175(5):851-859. PubMed ID: 27651098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia.
    Srivastava S; Tsongalis GJ; Kaur P
    Clin Biochem; 2013 Jul; 46(10-11):901-8. PubMed ID: 23518313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options.
    Gandhirajan RK; Poll-Wolbeck SJ; Gehrke I; Kreuzer KA
    Curr Cancer Drug Targets; 2010 Nov; 10(7):716-27. PubMed ID: 20578984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.